Boston Scientific inks $88M Elutia deal to challenge Medtronic

BTIG analysts estimate that Elutia’s Elupro and Medtronic’s TYRX are competing for a $600 million opportunity in the U.S. cardiac rhythm management sector.

Supreme Court to hear Trump’s tariff legality case in November

The high court granted an expedited review of an appellate court finding that the president's sweeping tariffs were illegal.

Pulse wins IDE approval; Galvanize pulls in $100M

Pulse Biosciences will study PFA in cardiac surgery. Meanwhile, Galvanize Therapeutics also named a new CEO, and PFA pioneer Steven Mickelsen has launched another company.

Microbot receives 510(k) clearance for endovascular robot

The company will now complete final commercial activities in preparation for targeting the 2.5 million peripheral vascular procedures performed in the U.S. each year.

Musk’s Neuralink says 12 people have received its implants

Apple introduces smartwatch feature designed to detect high blood pressure

RFK Jr.’s latest ‘Make America Healthy Again’ report calls for more scrutiny of vaccines and autism